SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alfacell (ACEL)
ACEL 11.09-2.1%Feb 11 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: r. parker griff who wrote (533)6/25/1997 12:04:00 AM
From: John Jenco   of 1533
 
rpg -- You've been sacked one too many times. <grin> Better hit the bench 'til your head clears...

-share price is flat
-volume is virtually non-existent
-options/warrants are expiring worthless left and right
-many shareholders (not just here) expressing concern to ACEL mgmt.
-cash burn rate seems to be accelerating above projection
-projected NDA milestone slipping further into '98
-overhead and G&A on the rise
-competitive products garnering most of the press/brokerage support
-no whiff of licensing agreement(s) in the wind
-last SIX (6) SEC 10Q's state "substantial talks" underway
-months of due diligence by brokerages and no conclusions

I don't know about you, but I find it difficult to characterize this as "good".

I want to be where I can see management making the right noises to the right people. I want to be where I can see some strategic partnerships forming. I want to be where I can see steadily rising share pricing and average daily trading volume. I want to be where I can watch the press and market giving Onconase and ACEL the credit they deserve... or are they? --John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext